Aman, M. G., Smedt, G., Derivan, A., et al (2002) Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviours in children with subaverage intelligence. American Journal of Psychiatry, 159, 1337–1346.
Baumeister, A. A., Sevin, J. A. & King, B. (1998) Neuroleptics. In Psychotropic Medications and Developmental Disabilities: The International Consensus Handbook (eds Reiss, S. & Aman, M. G.), pp. 133–150. Nisonger Center, Ohio State University.
Holmes, N., Shah, A. & Wing, L. (1982) The Disability Assessment Schedule: a brief screening device for use with the mentally retarded. Psychological Medicine, 12, 879–890.
Kay, S. R., Wolkenfield, F. & Murrill, L. M. (1988) Profiles of aggression among psychiatric patients. Journal of Nervous and Mental Disease, 176, 539–546.
Malt, U. F., Nystad, R., Bache, T., et al (1995) Effectiveness of zuclopenthixol compared with haloperidol in the treatment of behavioural disturbances in learning disabled patients. British Journal of Psychiatry, 166, 374–377.
Mikhail, A. G. & King, B. H. (2001) Self-injurious behaviour in mental retardation. Current Opinion in Psychiatry, 14, 457–461.
Singh, I. & Owino, W. J. (1992) Adouble-blind comparison of zuclopenthixol tablets with placebo in the treatment of mentally handicapped in-patients with associated behavioural problems. Journal of Intellectual Disability Research, 23, 541–549.
Yudofsky, S. C., Silver, J. M., Jackson, W.
et al (1986) The Overt Aggression Scale for the objective rating of verbal and physical aggression. American Journal of Psychiatry, 143, 35–39.